Visualization of phosphatidylcholine (16:0/16:0) in type II alveolar epithelial cells in the human lung using imaging mass spectrometry

Imaging mass spectrometry (MS) is an emerging technique that can detect numerous biomolecular distributions in a non‐targeting manner. In the present study, we applied a mass imaging modality, mass microscopy, to human lung tissue and identified several molecules including surfactant constituents in...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Pathology international 2013-04, Vol.63 (4), p.195-200
Hauptverfasser: Kurabe, Nobuya, Hayasaka, Takahiro, Igarashi, Hisaki, Mori, Hiroki, Sekihara, Keigo, Tao, Hong, Yamada, Hidetaka, Kahyo, Tomoaki, Onishi, Ippei, Tsukui, Hiroe, Kawase, Akikazu, Matsuura, Shun, Inoue, Yusuke, Shinmura, Kazuya, Funai, Kazuhito, Setou, Mitsutoshi, Sugimura, Haruhiko
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Imaging mass spectrometry (MS) is an emerging technique that can detect numerous biomolecular distributions in a non‐targeting manner. In the present study, we applied a mass imaging modality, mass microscopy, to human lung tissue and identified several molecules including surfactant constituents in a specific structure of the lung alveoli. Four peaks were identified using imaging MS, and the ion at m/z 772.5, in particular, was localized at some spots in the alveolar walls. Using an MS/MS analysis, the ion was identified as phosphatidylcholine (PC)(16:0/16:0), which is the main component of lung surfactant. In a larger magnification of the lung specimen, PC (16:0/16:0) was distributed in a mottled fashion in a section of the lung. Importantly, the distribution of PC (16:0/16:0) was identical to that of anti‐SLC34A2 antibody immunoreactivity, which is known to be a specific marker of type II alveolar epithelial cells, in the same section. Our experience suggests that imaging MS has excellent potential in human pathology research.
ISSN:1320-5463
1440-1827
DOI:10.1111/pin.12050